ATRI WELCOMES TWO INDUSTRY LEADERS TO ITS BOARD OF DIRECTORS

The American Transportation Research Institute (ATRI) has announced the appointment of two new members to its Board of Directors: https://mma.prnewswire.com/media/2813787/Ludwick_Kiely_new_board_members_of_American_Transportation_Research_Institute.jpg — Mike Ludwick, President and Chief Executive Officer, Bison USA, Winnipeg, MB — Michael Kiely, President, Global Government Affairs, UPS, Washington, DC The appointments were made by ATRI Chairman of the Board Derek Leathers, Werner […]

RCI Hospitality Holdings, Inc. (RICK) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of November 20, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / November 4, 2025 / If you suffered a loss on your RCI Hospitality Holdings, Inc. (NASDAQ:RICK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rci-hospitality-holdings-inc-lawsuit-submission-form?prid=175533&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Securities Lawsuit Alert: MoonLake Immunotherapeutics (MLTX) – Contact Levi & Korsinsky Before December 15, 2025

NEW YORK, NY / ACCESS Newswire / November 4, 2025 / If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=175534&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Early-Stage Funding Gaps a Priority with $750 Million in Federal Budget 2025

OTTAWA, Ontario, Nov. 04, 2025 (GLOBE NEWSWIRE) — Federal Budget 2025 marks meaningful progress in recognizing the critical role of early-stage capital and angel networks in providing entrepreneurs with the capital they need to transform innovation into commercialization. In response, Claudio Rojas, CEO of the National Angel Capital Organization issued the following statement: “We're pleased

NCLA Launches First Class-Action Lawsuit Against Trump’s Unlawful Emergency Tariff Orders

Washington, DC, Nov. 04, 2025 (GLOBE NEWSWIRE) — On the eve of Supreme Court oral argument tomorrow over the Trump Administration's orders imposing tariffs under the International Emergency Economic Powers Act (IEEPA), the New Civil Liberties Alliance has filed the first class-action complaint challenging those same executive actions, likewise arguing that IEEPA does not authorize

Angel Yeast starts Operating New 11,000-Ton Yeast Protein Production Line to Meet Global Demand for Sustainable Nutrition

Angel Yeast Co., Ltd. (SH600298) has officially started operations at its next-generation yeast protein production line at the Baiyang Biotechnology Park in Yichang, Hubei. The facility has an annual production capacity of 11,000 tons of high-purity yeast protein with a protein content exceeding 80%. This marks a key step in meeting growing global demand for

Early-Stage Funding Gaps a Priority with $750 Million in Federal Budget 2025

Early-Stage Funding Gaps a Priority with $750 Million in Federal Budget 2025 NACO applauds the Federal Government's recognition of Canada's early-stage infrastructure and the critical role of “capital and networks” in empowering entrepreneurs “to launch and scale resilient, high-impact companies” GlobeNewswire November 04, 2025 OTTAWA, Ontario, Nov. 04, 2025 (GLOBE NEWSWIRE) — Federal Budget 2025

NCLA Launches First Class-Action Lawsuit Against Trump’s Unlawful Emergency Tariff Orders

NCLA Launches First Class-Action Lawsuit Against Trump's Unlawful Emergency Tariff Orders Smirk & Dagger Games, B. Stuyvesant Champagne, LLC, Leo D. Bernstein & Sons Inc. d/b/a Bernstein Display v. President Donald J. Trump, et al. GlobeNewswire November 04, 2025 Washington, DC, Nov. 04, 2025 (GLOBE NEWSWIRE) — On the eve of Supreme Court oral argument

MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate — Hagens Berman

MLTX Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESS Newswire / November 4, 2025 / A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake (NASDAQ:MLTX) announced disastrous Phase 3 trial results for its only product candidate (sonelokimab, or "SLK"), its

Federal government takes an important first step to protect Canadians from the impacts of earthquakes

Today, the federal government released its budget. Following its release, Liam McGuinty, Vice-President, Federal Affairs, Insurance Bureau of Canada (IBC), issued the following statement: “With today's Budget, the federal government hassignalled its intent to consult with Canada's property and casualty (P&C) insurance industry on ways to ensure the stability of Canada's financial sector and broader

Scroll to Top